+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Archives

Loading Events

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?

Please join us as we discuss recent clinical data on water intake practices, feasibility of conducting water trials, and results of a randomized controlled trial of prescribed water intake in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). In this presentation the impact of water intake on ADPKD disease progression including Total Kidney Volume (TKV) will be discussed.

Featuring

Andrea Mohindra

Andrea Mohindra, PharmD

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Andrea Mohindra, PharmD, is a Nephrology Medical Science Liaison covering New York City & Long Island. She earned her PharmD at the University of Rhode Island in South Kingstown, RI. Prior to joining Otsuka in 2021, Dr Mohindra held various leadership roles in retail pharmacy for 15 years in the NJ and NYC regions. Most recently, she held the role of Doctor Partnership Manager for a retail pharmacy startup company and worked closely with Psychiatrists and Migraine Specialists. She is currently licensed in New Jersey and New York state.

Molly Jansen

Molly Jansen, PhD

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Drs Noto and Jansen are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:

Registration

Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.